[Ischaemic cholestasis in intensive care unit]
M Beaussier1, E Schiffer, C Housset
1Département d'anesthésie-réanimation chirurgicale, hôpital Saint-Antoine, AP-HP, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France. marc.beaussier@sat.aphp.fr
Insights
Ischaemic cholestasis in the ICU, often caused by hepatic artery issues, leads to poor outcomes. This condition involves bile duct proliferation and can cause liver fibrosis, potentially due to impaired hepatocyte transporters.
Area of Science:
- Hepatology and critical care medicine
Context:
- Cholestasis is a common complication in intensive care units (ICUs), frequently linked to adverse patient outcomes.
- Ischaemia is a significant, yet often overlooked, etiological factor contributing to cholestasis in the ICU setting.
Purpose:
- To highlight the role of ischaemia in inducing cholestasis within the ICU.
- To elucidate the pathological mechanisms and clinical implications of ischaemic cholestasis.
Summary:
- Ischaemia, particularly hepatic artery interruption, triggers cholestasis in ICUs, characterized by biliary proliferation and potential liver fibrosis.
- Resolution of cholestasis occurs spontaneously over weeks, though underlying hypoxia may disrupt hepatocyte bile salt transporters.
Impact:
- Understanding ischaemic cholestasis aids in managing ICU patients with liver dysfunction.
- This research may inform targeted therapies for cholestasis by addressing its ischaemic origins and transporter dysregulation.
Abstract:
Cholestasis is frequently encountered in the ICU and is associated with a poor outcome. Ischaemia should be considered among the numerous aetiologic factors that may trigger cholestasis in the ICU. Blood supply to biliary tract is mainly provided by the hepatic artery, throughout a peribiliary vascular plexus. Interruption of the hepatic artery blood supply leads to cholestasis with a concomitant proliferative biliary reaction. Bile duct proliferation persists, while bile flow restores and biologic cholestasis syndrome spontaneously resolves in several weeks. Liver fibrosis related to the activation of periportal mesenchymental cells is observed in the close vicinity of proliferative bile ducts. Ischaemic cholestasis can be ascribed, at least partly, to hypoxia-induced disorders in the expression of hepatocytes biliary salts membrane transporters.
Related Concept Videos
Cholecystitis
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
